Skip to main content

Table 3 Incidences of LLL according to risk factors

From: Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study

Variables

Variable category

No. of patients

No. of patients with LLL (%)

P-value

Age, (years)

<56

127

40 (31.5)

0.089

≥56

137

57 (41.6)

BMI, (kg/m2)

<25

194

66 (34.0)

0.145

≥25

70

31 (44.3)

Type of cancer

Cervix

78

26 (33.3)

0.569

Body

113

46 (40.7)

Tube

2

1 (50.0)

Ovary

68

24 (35.3)

Vagina

3

0 (0)

Extent of Lymphadenectomy

PLA

43

10 (23.3)

0.045

PLA + PALA

221

87 (39.4)

No. of LN

<42

128

43 (33.6)

0.202

≥42

136

54 (39.7)

LN metastasis

Yes

31

9 (29.0)

0.270

No

233

88 (37.8)

Retroperitoneal suture

Yes

202

78 (38.6)

0.609

No

62

19 (30.6)

Radiation therapy

Yes

17

9 (52.9)

0.298

No

247

88 (35.6)

Chemotherapy

Yes

182

65 (35.7)

0.423

No

82

32 (39.0)

Herbal medicine

Yes

10

6 (60.0)

0.108

No

254

91 (35.8)

Self-management education

Yes

120

38 (31.7)

0.724

No

144

59 (41.0)

Infection

Skin (cellulitis)

9

6 (66.7)

0.105

Lymphocyst

11

6 (54.5)

No

244

85 (34.8)

Lymphocyst formation

Yes

93

46 (49.5)

0.003

No

171

51 (29.8)

  1. Definition of abbreviations: IQR Interquartile range, BMI Body mass index, No. Number, LLL Lower limb lymphedema, LN Lymph node, PLA Pelvic lymphadenectomy, PALA Para-aortic lymphadenectomy